文献速递腹部MRCT

简化MRI联合可选多期CT替代全序列MRI:在HCC筛查队列中的LI-RADS验证

Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort.
PubMed 文献 · Eur Radiol · 2019-12-19

该多中心回顾性研究比较简化MRI(AMRI)联合多期CT与全序列钆塞酸增强MRI在HCC筛查队列中的诊断效能,按LI-RADS v2018标准评估。AMRI联合多期CT在LR-4/5标准下敏感度更高(96.4% vs 92.9%),准确度和阳性预测值相当。多期CT有潜力作为AMRI检出肝脏观察后HCC诊断的后续检查。

要点

  • AMRI联合多期CT在LR-4/5标准下敏感度显著高于全序列EOB-MRI(96.4% vs 92.9%)。
  • 两种方案在LR-4/5标准下准确度(91.2% vs 87.6%)和阳性预测值(94.1% vs 93.5%)相当。
  • 多期CT可作为HCC高危患者AMRI检出肝脏观察后的后续诊断模态。

关键影像表现/征象

  • AMRI联合多期CT与全序列EOB-MRI在LR-4/5标准下均将相似数量的非HCC恶性肿瘤归为LR-4或LR-5。
  • 两种方案均将相似数量的HCC归为LR-M。

诊断标准与关键数值

  • LR-4/5标准下,AMRI联合多期CT敏感度96.4%、准确度91.2%、阳性预测值94.1%;全序列EOB-MRI敏感度92.9%、准确度87.6%、阳性预测值93.5%。
  • LR-5标准下,AMRI联合多期CT敏感度66.4%、准确度67.7%、阳性预测值97.4%;全序列EOB-MRI敏感度70.4%、准确度70.6%、阳性预测值96.6%。

临床应用与阅片要点

  • 按LI-RADS v2018标准,AMRI联合多期CT可作为HCC高危患者AMRI检出肝脏观察后的后续检查选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the diagnostic performance of abbreviated MRI (AMRI) combined with multiphasic CT (mCT) with that of full-sequence gadoxetic acid-enhanced MRI (EOB-MRI) in a hepatocellular carcinoma (HCC)-screening cohort METHODS: Consecutive patients at risk of HCC who underwent EOB-MRI and mCT within 3 months for evaluation of new 0.5-3-cm hepatic observations were retrospectively recruited from 3 centers. An AMRI protocol comprising hepatobiliary phase, T2- and diffusion-weighted imaging, and dual-echo sequence was reconstituted from EOB-MRI. Two radiologists independently reviewed each observation in AMRI plus mCT (set 1) and EOB-MRI (set 2) per LI-RADS v2018. Per-lesion sensitivity, accuracy, and positive predictive value (PPV) for HCC were calculated and compared between image sets.

RESULTS: In 267 patients, 306 histologically confirmed observations (280 HCCs, 20 combined hepatocellular-cholangiocarcinomas, 1 cholangiocarcinoma, and 5 benignities) were assessed. Set 1 yielded higher sensitivity (96.4% vs. 92.9%, p = 0.013) and comparable accuracy (91.2% vs. 87.6%) and PPV (94.1% vs. 93.5%) to set 2 using LI-RADS category (LR)-4/5 criteria. The sets showed comparable sensitivity (66.4% vs. 70.4%), accuracy (67.7% vs. 70.6%), and PPV (97.4% vs. 96.6%) using LR-5 criteria. A similar substantial number of non-HCC malignancies were categorized as LR-4 or LR-5, as was the number of HCCs categorized as LR-M in both sets.

CONCLUSIONS: AMRI combined with mCT showed diagnostic performance similar or superior to that of EOB-MRI for HCC diagnosis using LI-RADS. Therefore, mCT holds potential as a sequential examination for HCC diagnosis in AMRI-detected hepatic observation in patients at risk of HCC.

KEY POINTS: • AMRI plus multiphasic CT showed comparable accuracy (91.2%) and PPV (94.1%) to full-sequence gadoxetic acid-enhanced MRI using LR-4/5 criteria. • AMRI plus multiphasic CT was significantly more sensitive than full-sequence gadoxetic acid-enhanced MRI (96.4% vs. 92.9%) using LR-4/5 criteria. • Multiphasic CT is a potential sequential modality for HCC diagnosis after AMRI.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park SH, Kim B, Kim SY, et al. Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort. Eur Radiol. 2019. PMID: 31858203. doi:10.1007/s00330-019-06546-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。